I've been around NBIX for many years as well. The other x-factor here is uterine fibroids. Abbvie is running that study and I don't believe they are under any obligation to release/share data. I believe that trial will complete this December. There is always the x-factor that Abbvie releases data in late 2013/early 2014 if that data is very strong. That would pop us up.